InVivoMAb anti-mouse Ly6C

Rowe AM, Yun H, Treat BR, et al. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen. J Immunol. 2017,198(4):1706-1717. doi: 10.4049/jimmunol.1601310

del Rio ML, Jones ND, Buhler L, et al. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction. J Immunol. 2012,188(10):4885-96. doi: 10.4049/jimmunol.1103698

Lubick K, Radke M, Jutila M. Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists. J Leukoc Biol. 2007,82(5):1062-9.

Duraiswamy N, Tse Y, Hammerberg C, et al. Distinction of class II MHC+ Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophages. J Invest Dermatol. 1994,103(5):678-83.

Jutila MA, Kroese FG, Jutila KL, et al. Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur J Immunol. 1988,18(11):1819-26.